Pro Share Advisors LLC Sesen Bio, Inc. Transaction History

Pro Share Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$0.0 - $0.93 $0 - $1,155	1,243 Added 8.0%	16,777 $7,000
Q2 2022 Aug 01, 2022	SELL	$0.38 - $0.89 $16,283 - $38,138	-42,852 Reduced 73.39%	15,534 $13,000
Q1 2022 May 10, 2022	SELL	$0.58 - $0.86 $7,935 - $11,766	-13,682 Reduced 18.98%	58,386 $34,000
Q4 2021 Feb 08, 2022	BUY	$0.73 - $1.28 $34,104 - $59,799	46,718 Added 184.29%	72,068 $59,000
Q3 2021 Nov 12, 2021	SELL	$0.77 - $4.91 $14,630 - $93,290	-19,000 Reduced 42.84%	25,350 $20,000
Q2 2021 Aug 13, 2021	BUY	$2.18 - $4.66 $96,683 - $206,671	44,350 New	44,350 $205,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.